Acthrel
Product Images NDC 55566-0302

2 FDA label images from Ferring Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acthrel (NDC 55566-0302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acthrelcortisonechart (Acthrel 01)

Acthrelcortisonechart (Acthrel 01)
A multi-panel line and spike graph showing time course data from 2000 to 0800 hours, with sections labeled LIGHT, DARK, LIGHT. The vertical axes measure hypophyseal portal plasma CRH (spikes), plasma ACTH in pg/mL (spikes), and total plasma cortisol in µg/dL (line graph). The graph depicts fluctuations of CRH, ACTH, and cortisol levels over time with two vertical dotted lines marking specific time points.*
FDA Label Image

Principal Display Panel (100 mcg Vial Label)

Principal Display Panel (100 mcg Vial Label)
Acthrel 100 mcg vial label for injection by Ferring Pharmaceuticals Inc. The label states the active ingredient as corticolin ovine triflutate, notes contents and excipients, instructions for reconstitution and storage at 2 to 8 degrees Celsius, and manufacturing details indicating Made in Germany, Parsippany, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.